Make-in-India for next generation treatment for

Recognising the potential of cell therapy by enhancing a key type of immune cell, Natural Killer (NK) cells, with new properties to create transformative cancer treatments for more patients. Using synthetic biology and non-viral cell engineering, it is possible to develop a highly potent allogeneic, off-the-shelf chimeric antigen receptor (CAR)-NK cell therapies capable of treating challenging cancers, including solid tumors, by combining new functional attributes with the inherent cancer-fighting properties of NK cells.